Tradestie Institutional Equity Comparison Engine

MTVA vs ENTX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ENTX Overall Edge

ENTX Captures Institutional Edge (2โ€“0 Pillars ยท 4โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Entera Bio Ltd. Ordinary Shares (ENTX) driven by superior Momentum & Technical, Options & Structure. Fundamentally, MTVA trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ENTX at N/M Forward P/E and 0.0% operating margin (-100.0% YoY). In options structure, MTVA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ENTX sits in CONSOLIDATION (33rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
MTVA N/M vs ENTX N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs -100.0%
Momentum & Technical Winner ENTX
1Y +32.2% vs +24.7% ยท 52W Pos 4% vs 73%
Options & Structure Winner ENTX
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (33rd %ile IV)
MTVA NASDAQ
MetaVia Inc. Common Stock
Pharmaceutical Preparations
$1.01
-5.61% 1D
Market Cap $7.2M
1M Return -27.34%
1Y Return +32.2%
Forward P/E N/M
Unified AI Score
48.0 / 100 HOLD
Tech 40.0 Fund 60.0 Flow 50.0 Mom 64.0
ENTX NASDAQ
Entera Bio Ltd. Ordinary Shares
Biological Products, (No Disgnostic Substances)
$3.31
+0.76% 1D
Market Cap $571.2M
1M Return +9.44%
1Y Return +24.72%
Forward P/E N/M
Unified AI Score
47.5 / 100 HOLD
Tech 52.0 Fund 49.0 Flow 72.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MTVA +32.2% ENTX +24.72% Spread: +7.48 pp (MTVA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
MTVA TTM Op. Margin: 0.0% ENTX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MTVA vs ENTX. Trailing 12-month operating profitability (MTVA 0.0% vs ENTX 0.0%) and valuation multiples (MTVA N/M vs ENTX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MTVA (2) vs ENTX (4)
Institutional Metric MTVA ENTX Criterion Row Winner
Market Capitalization Scale $7.2M $571.2M Larger Scale ENTX
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% -100.0% Higher Growth MTVA
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -175.7% -20.3% Higher ROE ENTX
52-Week Range Position Momentum 4% ($1โ€“$13) 73% ($1โ€“$4) Stronger Trend ENTX
Beta / 30D Volatility Risk Regime 1.30ฮฒ ยท 166% Vol 0.92ฮฒ ยท 53% Vol Lower Realized Risk ENTX
Unified Institutional Score Composite Signal 48.0 / 100 (HOLD) 47.5 / 100 (HOLD) Higher Composite MTVA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MTVA vs ENTX Buy Guide
MTVA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MTVA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ENTX CONSOLIDATION
83d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 33rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ENTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MTVA nor ENTX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.